(1R,3S)-3-(1H-Benzo[d]imidazol-2-yl)-1,2,2-tri­methyl­cyclo­pentane-1-carb­oxy­lic acid as a new anti-diabetic active pharmaceutical ingredient

Kovalenko, S.M.; Konovalova, I.S.; Merzlikin, S.I.; Chuev, V.P.; Kravchenko, D.V.

doi:10.1107/S2056989020010439

Acta Crystallographica Section E
Acta Crystallographica
Section E CRYSTALLOGRAPHIC COMMUNICATIONS

IUCr IT WDC

home archive editors for authors for readers submit open access

view article

Figure 6
(a) The two-dimensional fingerprint plot for compound 4, and those delineated into (b) H⋯H (61.7%), (c) C⋯H/H⋯C (18.1%), (d) O⋯H/H⋯O (13.5%) and (e) N⋯H/H⋯N (6.6%) contacts.

CRYSTALLOGRAPHIC
COMMUNICATIONS

ISSN: 2056-9890

Volume 76| Part 9| September 2020| Pages 1407-1411

https://doi.org/10.1107/S2056989020010439

Open

access

Follow Acta Cryst. E

Search IUCr Journals		doi		Advanced search
Author		volume	page